Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 11, 1998

View Archived Issues

Israeli investigators describe studies with novel vitamin D analogue

Hemosol: six-month 1998 highlights

Guilford: Q2 1998 highlights

IBT-9302 demonstrates therapeutic value in the treatment of traumatic shock

Medtronic releases novel cardiac device with diagnostic and therapeutic capabilities in Europe

OspA vaccine prevents Lyme disease and asymptomatic infection

4030W92 antihyperalgesic effect due to preferential action on slow activation state of Na+ channel

Professional advises against the use of antioxidant vitamins for the prevention of heart disease

Antifungal activity of NS-718 highly effective against C. neoformans infections

Dual-action angiotensin II blockers/smooth cell proliferation inhibitors from Bayer

Genentech discovers novel polypeptides for treating shock

New CNS agents described by French team

Yeda, Yissum collaborate in the discovery of tyrosine kinase inhibitors

Hoechst describes new compounds for rheumatoid arthritis and allergy

FDA committee recommends approval of Arava for the treatment of rheumatoid arthritis

Byk Gulden researchers synthesize PDE IV inhibitors with broad therapeutic potential

Bayer discovers new MMP inhibitors for arthritic diseases

Cognetix expands drug discovery capabilities with Viatech Imaging acquisition

COX-2 inhibitors selective for the human enzyme discovered at Nycomed Innovations

New agents for treating constipation presented at IUPHAR meeting

MABE: a new enkephalin analogue with analgesic potential

New antiplatelet agent, PDE III inhibitor, reported by Taiwanese scientists

Searle withdraws support for development of CCD-3693; CoCensys will forge ahead

Studies with spheron-targeted AD treatment candidate yield promising results

RS-601, a dual-action TxA2/LTD4 antagonist with potent antiasthmatic effects

Dual ETA/ETB antagonist provides effective blood pressure control in rats

OPC-51803, a vasopressin V2 agonist with potent antidiuretic activity in rats and dogs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...